Back to Results
First PageMeta Content
Pfizer / Cytomegalovirus vaccine / Viral diseases / Zurich Cantonal Bank / Human cytomegalovirus / Medicine / Health / Biology / Vaccines / Corporate crime / Dow Jones Industrial Average


Redbiotec sells CMV program to Pfizer Schlieren, Zurich, Switzerland[removed]Privately held Swiss Biopharmaceutical Company Redbiotec based in Zurich-Schlieren recently announced that it has sold Redvax GmbH, a spin-of
Add to Reading List

Document Date: 2015-01-11 09:20:52


Open Document

File Size: 179,49 KB

Share Result on Facebook
UPDATE